======= KIF2C ======= == Gene Information == * **Official Symbol**: KIF2C * **Official Name**: kinesin family member 2C * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11004|11004]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q99661|Q99661]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KIF2C&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KIF2C|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604538|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: In complex with KIF18B, constitutes the major microtubule plus-end depolymerizing activity in mitotic cells (PubMed:21820309). Regulates the turnover of microtubules at the kinetochore and functions in chromosome segregation during mitosis (PubMed:19060894). Plays a role in chromosome congression and is required for the lateral to end-on conversion of the chromosome- microtubule attachment (PubMed:23891108). {ECO:0000269|PubMed:19060894, ECO:0000269|PubMed:21820309, ECO:0000269|PubMed:23891108}. |Kinesin| |establishment or maintenance of microtubule cytoskeleton polarity| |centromeric DNA binding| |attachment of mitotic spindle microtubules to kinetochore| |establishment or maintenance of cytoskeleton polarity| |microtubule plus-end binding| |microtubule depolymerization| |attachment of spindle microtubules to kinetochore| |microtubule plus-end| |protein depolymerization| |mitotic metaphase plate congression| |microtubule polymerization or depolymerization| |cytoplasmic microtubule| |kinesin complex| |chromosome, centromeric region| |metaphase plate congression| |microtubule motor activity| |establishment of chromosome localization| |chromosome localization| |retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum| |kinetochore| |condensed chromosome kinetochore| |antigen processing and presentation of exogenous peptide antigen via MHC class II| |antigen processing and presentation of peptide antigen via MHC class II| |antigen processing and presentation of peptide or polysaccharide antigen via MHC class II| |regulation of chromosome segregation| |mitotic sister chromatid segregation| |cellular protein complex disassembly| |sister chromatid segregation| |mitotic nuclear division| |microtubule cytoskeleton| |antigen processing and presentation of exogenous peptide antigen| |antigen processing and presentation of exogenous antigen| |antigen processing and presentation of peptide antigen| |establishment or maintenance of cell polarity| |antigen processing and presentation| |nuclear chromosome segregation| |ATPase activity| |microtubule binding| |protein-containing complex disassembly| |microtubule-based movement| |chromosome segregation| |nuclear division| |organelle fission| |microtubule| |establishment of organelle localization| |Golgi vesicle transport| |cellular component disassembly| |supramolecular fiber organization| |microtubule cytoskeleton organization| |centrosome| |cell division| |organelle localization| |mitotic cell cycle process| |microtubule-based process| |mitotic cell cycle| |cell cycle process| |chromosome organization| |cytoskeleton organization| |cell cycle| |ATP binding| |movement of cell or subcellular component| |establishment of localization in cell| |protein-containing complex subunit organization| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp103|Taxol 0.004μM R03 exp103]]|-4.17| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-3.2| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-2.89| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|-2.44| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|-2.29| |[[:results:exp223|Cabazitaxel 0.001μM R05 exp223]]|-2.08| |[[:results:exp159|Docetaxel 0.001 to 0.002μM on day4 R04 exp159]]|-1.93| |[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|-1.85| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-1.73| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|-1.7| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|1.95| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|2.05| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|2.1| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|2.53| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|3.29| |[[:results:exp59|UMK57 1μM R01 exp59]]|4.44| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|5.88| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|5.95| ^Gene^Correlation^ |[[:human genes:k:kif18b|KIF18B]]|0.762| |[[:human genes:p:ppp2r5c|PPP2R5C]]|0.463| |[[:human genes:k:kif4a|KIF4A]]|0.435| |[[:human genes:c:clasp2|CLASP2]]|0.405| Global Fraction of Cell Lines Where Essential: 23/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|3/56| |cervix|0/4| |colorectal|1/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|5/21| |liver|0/20| |lung|1/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|3/24| |soft tissue|1/9| |thyroid|0/2| |upper aerodigestive|3/22| |urinary tract|1/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8767 * **Expression level (log2 read counts)**: 7.14 {{:chemogenomics:nalm6 dist.png?nolink |}}